Lewes, DE -- (SBWIRE) -- 10/02/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Pan American Silver Corp. (USA) (NASDAQ:PAAS), Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), American Capital Ltd. (NASDAQ:ACAS), Delcath Systems, Inc. (NASDAQ:DCTH).
Pan American Silver Corp. (USA) (NASDAQ:PAAS), decreased -2.46% and closed at $10.29 on a traded volume of 2.80 million shares, in comparison to 3.26 million shares of average trading volume. So far this year, the stock is down over-45.06%.
The company has a total market capitalization of $1.65Billion and its total outstanding shares are 160.41million.
Will PAAS Get Buyers Even After The Recent Rally? Find Out Here
Pan American Silver Corp. (Pan American), engaged in the operation and development of, and exploration for, silver producing properties and assets. Pan American’s principal product is silver, although gold, zinc, lead, and copper are also produced and sold.
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), soared/ 1.41% and closed at $15.08 on a traded volume of 2.81 million shares, whereas its average trading volume is 1.66 million shares. In the last three months, the stock is up13.55%. The Intra-day range for the stock is $14.85 and $15.24.
Will MDRX Continue To Move Higher? Find Out Here
Allscripts Healthcare Solutions, Inc. (Allscripts) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
American Capital Ltd. (NASDAQ:ACAS), jumped up0.87% and closed at $13.87. So far in three months, the stock is up 7.77%. The 52-week range for the stock is $11.12 and $15.24 and during the previous trading session it marked$13.98 as its highest price. The stock initially exchanged hands with a price of $13.75 and the overall traded volume that day was 2.78 million shares.
Will ACAS Continue To Move Higher? Find Out Here
American Capital, Ltd. (American Capital) is an equity firm and global asset manager. American Capital invests in private equity, private debt, private real estate securities and other investments, technology investments, special situation investments, alternative asset funds managed by the Company.
Delcath Systems, Inc. (NASDAQ:DCTH) after opening its shares at the price of $0.34, dropped -5.98% to close the day at $0.308. The stock ended on a traded volume of 3.20 million shares, in comparison to1.51million shares of average trading volume. The 52-week range for the stock is $0.29 and $2.38 and during the previous trading session the stock scored the highest price of $0.34. It started the day at $0.34.
Will DCTH Get Buyers Even After The Recent Rally? Find Out Here
Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/